Company Filing History:
Years Active: 2024
Title: Yoshinobu Ichiki: Innovator in Monoclonal Antibody Research
Introduction
Yoshinobu Ichiki is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His innovative work has the potential to impact various medical applications.
Latest Patents
Ichiki holds a patent for a monoclonal antibody and its use. The patent describes a monoclonal antibody or a fragment thereof, which includes specific amino acid sequences in its heavy-chain and light-chain complementarity-determining regions (CDRs). This invention has binding properties to the KK-LC-1 protein, which is crucial for various therapeutic applications.
Career Highlights
Yoshinobu Ichiki is affiliated with the Kitasato Institute, where he conducts his research. His work has led to advancements in the understanding and application of monoclonal antibodies in medicine. He has been recognized for his contributions to the field and continues to be an influential figure in biotechnology.
Collaborations
Ichiki has collaborated with notable colleagues, including Takashi Fukuyama and Hitoshi Yamazaki. These partnerships have fostered a collaborative environment that enhances research and innovation in their respective fields.
Conclusion
Yoshinobu Ichiki's work in monoclonal antibody research exemplifies the importance of innovation in biotechnology. His contributions are paving the way for future advancements in medical treatments.